Cyclerion Therapeutics (CYCN) Long-Term Investments (2023 - 2025)

Cyclerion Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Long-Term Investments changed 0.0% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $5.4 million (changed 0.0% YoY), while the FY2025 annual figure was $5.4 million, changed 0.0% from the prior year.
• Long-Term Investments was $5.4 million for Q4 2025 at Cyclerion Therapeutics, roughly flat from $5.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q3 2023 to a low of $5.4 million in Q3 2023.
• Historically, Long-Term Investments has averaged $5.4 million across 3 years, with a median of $5.4 million in 2023.
• Biggest YoY gain for Long-Term Investments was 0.0% in 2024; the steepest drop was 0.0% in 2024.
• A 3-year view of Long-Term Investments shows it stood at $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
• The last three Long-Term Investments figures came in at $5.4 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.